Prevalence and Determinants of Anemia During the Third Trimester of Pregnancy

NCT05479799 | Completed

• 1 other identifier: anemia in pregnancy: Beni-Suef
• Study Type: observational
• Target: 383
• Locations: 1 country
• Sites: 1

Brief Summary

This cross-sectional study was conducted on 383 pregnant women who attended the antenatal care clinic during their third trimester at Beni-Suef University Hospital. A proper history was taken from each participant. All women were subjected to routine antenatal care, including physical examinations, ultrasound examinations, and routine laboratory tests. According to WHO criteria, anemia was diagnosed with a hemoglobin level of less than 11.0 g/dl. Anemia was further divided into three degrees; mild with hemoglobin level 10-10.9 g/dl, moderate with hemoglobin level 7-9.9 g/dl, and severe with hemoglobin level \< 7.0 g/dl.

Conditions

Anemia of Pregnancy

Keywords

Anemia; Hemoglobin; Third trimester; Pregnancy outcome

Outcome Measures

Primary Outcomes (1)

• Number of participants with the prevalence of anemia in the third trimester of pregnancy

  Number of participants with the prevalence of anemia in the third trimester of pregnancy in a specific geographical area (Beni-Suef University Hospital as a tertiary referral center)

  through study completion (3-6 months)

Study Arms (2)

Anemia group

anemia was diagnosed with a hemoglobin level of less than 11.0 g/dl

Non-anemia group

Normal hemoglobin was diagnosed with a hemoglobin level of more than 11.0 g/dl

Eligibility Criteria

• Age: 18 Years - 42 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

The study included pregnant women who attended the antenatal care clinic during their third trimester.

You may qualify if:

• pregnant women during their third trimester

You may not qualify if:

• Women with chronic medical illness

Sponsors & Collaborators

• Beni-Suef University: lead

Study Sites (1)

Beni-Suef University

Banī Suwayf, Egypt

Location

MeSH Terms

Conditions

Anemia

Condition Hierarchy (Ancestors)

Hematologic Diseases; Hemic and Lymphatic Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: July 27, 2022
• First Posted: July 29, 2022
• Study Start: January 4, 2019
• Primary Completion: June 30, 2019
• Study Completion: June 30, 2019
• Last Updated: July 29, 2022

Record last verified: 2022-07

Locations

EG (1)